Asia
GlaxoSmithKline plc today announced that it has successfully completed the acquisition of TESARO, Inc. an oncology-focused company based in Waltham, Massachusetts, for an aggregate cash consideration of approximately $5.1 billion (£4.0 billion).
Wilson W. Cheung, CPA appointed Chief Financial Officer
Highest Ranked Japanese Company
As opioid lawsuits continue to wind through the courts, some drugmakers are focused on developing treatments for opioid addiction.
Researchers from A*STAR’s SBIC have discovered how changes in BCAA metabolism influence the development and progression of tumours, and pave the way for new approaches to prevent and treat certain cancers
Cerner to unveil an immersive Motion Health experience and share at its booth interactive talks about the current and future health care landscape
China government officials told the Xinhua News Agency that the researcher who became world famous for using CRISPR on human embryos “will be transferred to public security authorities,” and the individuals involved in the research will be “severely dealt with according to the law.”
The U.S. Food and Drug Administration (FDA) approved South Korea’s Samsung Bioepis’ Ontruzant (trastuzumab-dttb), a biosimilar to Genentech’s Herceptin (trastuzumab).
Pharma and biotech companies make changes to their board and leadership teams to advance pipelines and strategies, at SQZ, AstraZeneca, Bioasis, and more.
Aiming at a service which prevents dementia and enables a society of healthy longevity
PRESS RELEASES